ArticleBMC pregnancy and childbirth2026
Atypical amniotic fluid embolism presenting with isolated coagulopathy: a case report.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundAmniotic fluid embolism (AFE) is a rare but catastrophic obstetric complication characterised by the sudden entry of amniotic fluid or fetal components into the maternal circulation, triggering severe cardiorespiratory collapse, coagulopathy, or both. While most patients exhibit abrupt hypotension and hypoxia, a coagulopathy-dominant subtype has increasingly been recognised but remains easily overlooked. Its insidious onset and absence of overt cardiopulmonary signs often delay recognition and appropriate intervention. CASE PRESENTATION: We report a 30-year-old Chinese woman (gravida 2, para 1) who developed severe coagulopathy-dominant AFE shortly after the vaginal delivery of a term singleton infant at a tertiary comprehensive hospital. She presented exclusively with massive postpartum bleeding and precipitous drops in fibrinogen (3.21→ 0.37 g/L within 15 min) and platelets (96→46 × 10⁹/L), without hypoxia or cardiopulmonary compromise. Recognising the disproportionate coagulopathy, clinicians rapidly initiated a protocol involving massive transfusion emphasising early fibrinogen supplementation, followed by timely surgical intervention. Despite profound disseminated intravascular coagulation and recurrent haemorrhage, coordinated multidisciplinary management resulted in complete recovery without sequelae.
conclusionsThis case highlights an atypical, coagulopathy-dominant case of AFE in which rapid recognition of isolated coagulopathy and early fibrinogen-guided transfusion likely avoided a fatal outcome. Vigilant monitoring and prompt, team-based intervention are essential to improving survival in such non-classical AFE presentations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.